See more : Ping An Securities Group (Holdings) Limited (0231.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Sera Prognostics, Inc. (SERA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sera Prognostics, Inc., a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
You may be interested
- Samyang Holdings Corporation (000075.KS) Income Statement Analysis – Financial Results
- Ulta Beauty, Inc. (ULTA) Income Statement Analysis – Financial Results
- LY Corporation (4689.T) Income Statement Analysis – Financial Results
- Sharanam Infraproject And Trading Limited (SIPTL.BO) Income Statement Analysis – Financial Results
- Hemnet Group AB (publ) (HMNTY) Income Statement Analysis – Financial Results
Sera Prognostics, Inc. (SERA)
About Sera Prognostics, Inc.
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 306.00K | 268.00K | 82.00K | 25.00K | 36.00K |
| Cost of Revenue | 210.00K | 193.00K | 37.00K | 11.00K | 18.00K |
| Gross Profit | 96.00K | 75.00K | 45.00K | 14.00K | 18.00K |
| Gross Profit Ratio | 31.37% | 27.99% | 54.88% | 56.00% | 50.00% |
| Research & Development | 15.23M | 14.24M | 11.02M | 7.78M | 9.35M |
| General & Administrative | 16.34M | 16.78M | 14.09M | 6.56M | 4.28M |
| Selling & Marketing | 8.35M | 14.70M | 10.33M | 3.65M | 2.96M |
| SG&A | 24.69M | 31.48M | 24.42M | 10.20M | 7.24M |
| Other Expenses | 0.00 | 1.53M | 1.13M | -80.00K | -17.00K |
| Operating Expenses | 39.92M | 45.73M | 35.44M | 17.99M | 16.58M |
| Cost & Expenses | 40.13M | 45.92M | 35.48M | 18.00M | 16.60M |
| Interest Income | 1.64M | 456.00K | 145.00K | 42.00K | 64.00K |
| Interest Expense | 55.00K | 61.00K | 746.00K | 1.84M | 1.97M |
| Depreciation & Amortization | 900.00K | 1.22M | 659.00K | 895.00K | 946.00K |
| EBITDA | -35.29M | -42.91M | -33.60M | -17.11M | -13.60M |
| EBITDA Ratio | -11,531.70% | -16,464.55% | -41,784.15% | -68,456.00% | -37,786.11% |
| Operating Income | -39.82M | -45.65M | -35.40M | -17.97M | -16.56M |
| Operating Income Ratio | -13,013.40% | -17,034.33% | -43,164.63% | -71,884.00% | -45,997.22% |
| Total Other Income/Expenses | 3.58M | 1.47M | 386.00K | -1.88M | 55.00K |
| Income Before Tax | -36.24M | -44.19M | -35.01M | -19.85M | -16.52M |
| Income Before Tax Ratio | -11,843.79% | -16,487.31% | -42,693.90% | -79,392.00% | -45,891.67% |
| Income Tax Expense | 0.00 | 61.00K | 1.22M | 1.76M | 3.92M |
| Net Income | -36.24M | -44.25M | -36.23M | -21.61M | -20.44M |
| Net Income Ratio | -11,843.79% | -16,510.07% | -44,180.49% | -86,428.00% | -56,775.00% |
| EPS | -1.16 | -1.43 | -1.18 | -0.70 | -0.67 |
| EPS Diluted | -1.16 | -1.43 | -1.18 | -0.70 | -0.67 |
| Weighted Avg Shares Out | 31.20M | 30.94M | 30.77M | 30.70M | 30.70M |
| Weighted Avg Shares Out (Dil) | 31.20M | 30.94M | 30.77M | 30.70M | 30.70M |
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023
SALT LAKE CITY , July 31, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report...
SIERRA NORTHERN RAILWAY AWARDED FUNDING BY THE CALIFORNIA STATE TRANSPORTATION AGENCY TO BUILD THREE ADDITIONAL ZERO EMISSION SWITCHING LOCOMOTIVES
WEST SACRAMENTO, Calif., July 6, 2023 /PRNewswire/ — Sierra Northern Railway (SERA) continues to lead the industry in the conversion of diesel locomotives to hydrogen-fueled, zero- emission locomotives. On July 6, 2023 the California State Transportation Authority announced that it...
Sera Prognostics: Buy The PreTRM Moat
Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies biomarkers linked to premature birth. Premature birth is a significant issue, with 1 in 10 babies born prematurely in...
Sera Prognostics, Inc. (SERA) Reports Q1 Loss
Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.40 per share a year ago.
All You Need to Know About Sera Prognostics, Inc. (SERA) Rating Upgrade to Buy
Sera Prognostics, Inc. (SERA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sera Prognostics, Inc. (SERA) Q4 2022 Earnings Call Transcript
Sera Prognostics, Inc. (NASDAQ:SERA ) Q4 2022 Earnings Conference Call March 22, 2023 5:00 PM ET Company Participants Peter DeNardo - CapComm Partners, IR Greg Critchfield - President and CEO Jay Moyes - CFO Conference Call Participants Patrick Donnelly -...
Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates
Sera Prognostics, Inc. (SERA) delivered earnings and revenue surprises of 26.19% and 50%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
SERA PROGNOSTICS TO PRESENT AT UPCOMING MARCH INVESTOR CONFERENCES
SALT LAKE CITY , Feb. 23, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present...
SERA Stock: 127.69% Surge This Week Explanation
The stock price of Sera Prognostics Inc (NASDAQ: SERA) surged by 127.69% this past week. This is why.
3 Common Myths About Penny Stocks Debunked
Debunking common myths about trading penny stocks in 2023 The post 3 Common Myths About Penny Stocks Debunked appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Source: https://incomestatements.info
Category: Stock Reports